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Biochemical and partial sequence data reveal the two-domain structure of ~36. A loose structure of some 
30 residues at the amino-terminus contains the phospho~latable tyrosine and the binding site for the pl 1 
regulatory chain. The following ~33 domain retains the lipid-binding site as well as the Caz+ site which influ- 
ences the spectral properties of the single tryptophan and one tyrosine. The combined sequence data cover- 
ing about 25% of the molecule identify p36 as a unique polypeptide. 
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1. INTRODUCTION 
Certain oncogenic viruses encode tyrosine- 
specific protein kinases and reiated enzymatic ac- 
tivities are known to be associated with receptors 
for some growth factors (review [l]). A major 
cellular substrate of fibroblasts transformed by 
retroviruses is a 36 kDa protein, called ~36. 
Although it has been known for several years, 
neither the function of p36 nor the possible impor- 
tance of its phosphorylation has emerged. With the 
realization that p36 can be purified in large 
amounts from intestinal epithelium [2], molecular 
properties could be established which may finally 
help in understanding the role of this protein, 
which is considered as membrane and/or 
cytoskeletal element [2,3]. 
p36 is a Ca 2+-binding protein of moderate af- 
finity [2,3] and this binding seems to be enhanced 
by phosphatidylserine (PS) but not by 
phosphatidylcholine (PC) [4]. Ca*+ binding in- 
duces a large conformational change exposing the 
single tryptophan and at least one tyrosine to a 
more aqueous environment [3]. This molecular 
change also leads to in vitro binding to F-actin and 
spectrin, the physiological importance of which is 
not understood [2,3]. p36 can exist either as a 
monomer or as a complex (protein I) containing 
two copies of p36 and a dimer of a unique pll 
polypeptide [2,3]. pl 1 is related by amino acid se- 
quence to S-100 [5,6], a protein with unknown 
function. Here we explore the binding sites of p36 
and characterize the protein by further 
biochemical properties as well as by partial amino 
acid sequences. 
2. MATERIALS AND METHODS 
Porcine protein I and subunits p36 and pl I were 
obtained from intestinal epithelium [2,3] using the 
modification given in 151. Ca2+ ultraviolet dif- 
ference spectra were recorded as described f3]. In 
vitro proteolysis of protein I and p36 was perform- 
ed at 20°C in 20 mM imidazole-HCI (pH 7.4), 
90 mM NaCl, 0.5 mM DTT, 2 mM NaN3 using 
either Ca2+ or EGTA at 1 mM. Proteins were pre- 
sent at about 1 mglml and enzymes at 
0.005 mglml. Proteolysis was stopped by either 
the addition of the hot sample buffer used for gel 
electrophoresis or phenylmethylsulfonyl fluoride 
(PMSF) to 2.5 mM. For p33 isolation, p36 was 
treated with chymotrypsin for 25 min in 0.1 M 
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NH4HC03. After addition of PMSF gel filtration 
was executed in 0.1 M NH4HC03 on Sephadex 
G-100. Alternatively the digest was lyophilized and 
p33 purified by HPLC. Lipid binding was carried 
out in 20 mM imidazole-HCl (pH 7.4), 80 mM 
NaCl, 2 mM MgC12, 0.5 mM DTT using either 
1 mM EGTA or 0.1 mM CaC12 and PS-containing 
liposomes (1 mg/ml). After centrifugation 
(20 min, 300000 x g) corresponding aliquots of 
supernatant and pellets were characterized by SDS- 
polyacrylamide gel electrophoresis. Molecular 
masses of derivatives were deduced from gel filtra- 
tion [2,3]. For fast screening of digestion condi- 
tions, gel filtration was performed by FPLC (Phar- 
macia) in EGTA-containing Tris buffer on a 
Superose S12 column. Cleavage at tryptophan with 
BNPS-skatole was performed on p36 previously 
carboxymethylated with iodoacetic acid in 8 M 
urea using standard conditions [7]. 
3. RESULTS 
During purification of protein I [2,3] a pro- 
teolytic derivative of p36 elutes earlier on the car- 
boxymethylcellulose column. This derivative, ~34, 
is recognized by antibodies to p36 in immunoblots 
and is a monomer in gel filtration. Gel elec- 
trophoresis shows that p34 lacks the pll subunit. 
In the search for a similar derivative available in 
large amounts, in vitro proteolysis of protein I and 
p36 was studied (fig.1). Trypsin yielded a p33 
which was time-dependently digested further into 
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Fig.1. Chymotryptic leavage of protein I (lane A) 
provides a stable p33 (lane B) leaving pll intact. Gel 
pattern of p36 after treatment with BNPS-skatole in lane 
C. 
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Fig.2. Sequence results on fragments of porcine ~36. (a) 
The chymotryptic p33 derivative starts at residue 30 and 
the determined sequence continues to residue 64. X 
indicates a not yet identified residue. This sequence of 35 
residues (underlined) overlaps by 8 residues with the 
previously reported 28 residues (dotted) of bovine p36 
[6]. (b) The 21 residues following the single tryptophan 
(W) of porcine ~36. Residue numbers are estimated from 
the size of the fragments obtained by BNPS-skatole 
cleavage (see text). Note that the single tryptophan and 
the phosphorylatable tyrosine (indicated by an asterisk) 
are widely separated in the linear sequence. 
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Fig.3. Calcium-induced difference spectra of p36 (A) 
and its proteolytic p33 derivative (B). Protein 
concentrations were 0.8 (A) and 1.1 mg/ml (B), 
respectively. 
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smaller fragments. As this process was enhanced 
by EGTA a Ca2+-binding site was indicated for 
p33. Chymotrypsin, however, provided in- 
dependently of calcium or EGTA a p33 of high 
stability. This derivative was purified. When in a 
digest of protein I, p36 was completely converted 
to ~33, the pll was not changed and could again 
form protein I once p36 was added. 
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Fig.4. Gel filtration on Superose S12 monitored by 
FPLC. Protein I (A) was treated with chymotrypsin for 
1 min (B) and 18 min (C) before addition of PMSF. 
Control experiments showed the elution positions of 
protein I(ll.7 ml), p36 and p33 (13.7 ml) and pll dimer 
(13.8 ml). Gels shown in B and C are for protein I (lanes 
a; control), chymotryptic digest before gel filtration 
(lanes b) and the fractions corresponding to 11.7 and 
Fig.5. Binding to PS liposomes monitored by co- 
sedimentation and gel electrophoresis. p, pellets; s, 
supernatants. Results are for protein I (lanes A,B), p36 
(lanes C-F), p33 (lanes G-J) and pll (lanes K-N). 
Assays were in Ca2+ (lanes A-D,G,H,K,L) or in EGTA 
(other lanes). Binding of p36 and p33 is Ca*+ dependent 
but reduced in comparison to protein I. pl 1 shows only 
13.7 ml, respectively (lanes c,d). background binding in the presence of Ca’+. 
While p36 has a blocked N-terminus, a run of 
p33 on the gas-phase sequenator yielded a unique 
sequence of 35 residues (fig.2). Of the proteolyzed 
3 kDa domain two smaller peptides were isolated 
and characterized but the peptide carrying the 
blocking group, possibly myristic acid [8], has not 
yet been recovered from the HPLC. p33 as well as 
p34 retain the Ca2+ -induced ultraviolet difference 
spectrum typical for p36 (fig.3). This is 
characterized by the exposure of the sole tryp- 
tophan and at least one tyrosine to a more aqueous 
environment in the presence of the ligand [3]. The 
relative position of the tryptophan in the p36 
molecule was mapped. Cleavage at tryptophan of 
S-carboxymethylated p36 using BNPS-skatole pro- 
vided two fragments of p36 (fig.1). While the 
larger 23 kDa fragment retains the blocked N- 
terminus of ~36, the smaller 13 kDa fragment 
could be sequenced for 21 residues (fig.2). Thus 
the sole tryptophan is about 200 residues removed 
from the N-terminus of ~36. The two sequence 
stretches established (fig.2) account for about 25% 
of the p36 sequence and were unique when entered 
into the Protein Sequence Data Bank of the Na- 
tional Biomedical Research Foundation. 
Purified p33 as well as p34 behaved as 
monomers in gel filtration. Their elution profile 
llK-- I* I 
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did not shift when mixed with pll. Control ex- 
periments with p36 showed as before [3] 
reconstitution to the tetrameric complex contain- 
ing two copies each of p36 and pl 1. Thus the pro- 
teolytic removal of about 30 residues from the N- 
terminus of p36 results in a p33 domain unable to 
bind pll (fig.4). p33 also retains the 
Ca2+-dependent interaction with F-actin (not 
shown). Liposomes of PS bound protein I in the 
presence of Ca2+ (see also [4]). This binding 
(figS), although somewhat weaker, is retained in 
monomeric p36 and ~33, while pll failed to bind 
above background levels. 
4. DISCUSSION 
We have delineated two structural domains of 
~36. The amino-terminal 30 residues are necessary 
to bind pl 1, which induces the complex (protein I) 
of two copies each of p36 and pl 1. The carboxy- 
terminal p33 domain carries the Ca2’ site influenc- 
ing the environment of at least one tyrosine and the 
sole tryptophan now mapped to position 200 
(fig.2). This domain also harbors the lipid-binding 
site. The partial amino acid sequences accumulated 
during the characterization of the domains cover 
about 25% of the molecule and identify p36 as a 
unique protein. 
Under in vitro conditions tyrosine phosphoryla- 
tion is stimulated by Ca2+ [3,5,9]. Thus at least two 
tyrosines are influenced by Ca2+. The 
phosphorylatable tyrosine which is mapped in the 
amino-terminal region, and a second tyrosine, 
which is located in ~33. The latter tyrosine changes 
its spectral properties together with the tryp- 
tophan. The Ca’+-induced enhancement of 
phosphorylation most likely arises from a confor- 
mational influence of the p33 domain on the 
amino-terminal domain. That monomeric p36 
seems a better substrate than the complex with pll 
[9] is in line with a binding site for pll in the 
amino-terminal domain. When we used secondary 
structure prediction rules [lo] the tyrosine 
phosphate is present within a stretch containing 
several p-turns (residues 6-17) while the cleavage 
point for chymotrypsin precedes a short, putative- 
ly a-helical element (residues 24-32). 
Myristylation of p36 in fibroblasts was not 
detected in [l I] although a more recent report [8] 
has raised this possibility. The amino-terminus of 
p36 is blocked ([6] and above) but the nature of the 
blocking group is unknown. It will become 
available once the very amino-terminal peptide can 
be isolated from the chymotryptic digest which 
leads to ~33. However, even if it was a fatty acid 
our results show that the lipid-binding site of p36 
resides in the carboxy-terminal p33 domain. As 
shown for the Ca2+-induced binding of protein I 
and p36 to F-actin and spectrin [2,3], binding to 
PS was more effective with protein I, which con- 
tains two p36 molecules, than with monomeric p36 
or ~33. Turbidity measurements implicate protein 
I in Ca2+-dependent aggregation of PS liposomes. 
Future experiments should characterize the se- 
quences involved in lipid and Ca’+-binding in 
order to understand the interaction between the 
two sites. 
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